The Court’s new majority has its first chance to take a shot at Roe v. Wade.
By Ian Millhiser
Dec 17, 2020
Last October, the Supreme Court handed down a fairly surprising order in an abortion case.
FDA v. American College of Obstetricians and Gynecologists concerns whether patients should have an easier time obtaining a pill used in medication abortions while the Covid-19 pandemic is still raging, but the Trump administration saw in the case an opportunity to drastically roll back abortion rights. One of the administration’s arguments could force abortion patients to have unnecessary surgeries instead of receiving a far less invasive medication abortion, and it could potentially deny abortions to many people altogether.